Статья: Непереносимость углеводов

Внимание! Если размещение файла нарушает Ваши авторские права, то обязательно сообщите нам

26.Mattar R., de Campos Mazo D.F., Carrilho F.J. Lactose intolerance: diagnosis, genetic, and clinical factors. Clin Exp Gastroenterol 2012;5:113-21.

27.Shaukat A., Levitt M.D., Taylor B.C. et al. Systematic review: effective management strategies for lactose intolerance. Ann Intern Med 2010 Jun 15;152(12):797-803.

28.Montalto M., Curigliano V., Santoro L. et al. Management and treatment of lactose malabsorption. World J Gastroenterol 2006;12(2):187-91.

29.Labayen I., Forga L., Gonzбlez A. et al. Relationship between lactose digestion, gastrointestinal transit time and symptoms in lactose malabsorbers after dairy consumption. Aliment Pharmacol Ther 2001 Apr;15(4):543-9.

30.Vallaeys L., van Biervliet S., de Bruyn G. et al. Congenital glucose-galactose malabsorption: A novel deletion within the SLC5A1 gene. Eur J Pediatr 2013; 172:409-11.

31.Bothinah Ghazali, Sultan A. Almedhesh, Ali M. Alsuheel et al. Congenital glucose-galactose malabsorption: A rare cause of chronic diarrhea. Intern J Med Medical Scienc 2014; 6(2):59-62.

32.Gomara R.E., Halata M.S. Fructose intolerance in children presenting with abdominal pain. J Pediatr Gastroenterol Nutr 2008; 47:303-8.

33.Jones H.F., Butler R.N., Brooks D.A. Intestinal fructose transport and malabsorption in humans. Am J Physiol Gastrointest Liver Physiol 2011; 300:G202-G206.

34.Ledochowsky M., Widner B., Bair H. et al. Fructose and sorbitol reduced diet improves mood and gastrointestinal disturbances in fructose malabsorbers. Scand J Gastroentrol 2000; 35:1048-52.

35.Frieling T. Fructose malabsorption: how much fructose can a healthy subject tolerate? Digestion 2011; 84:269-72.

36.Puntis J.W., Zamvar V. Congenital sucrase-isomaltase deficiency: Diagnostic challenges and response to enzyme replacement therapy. Arch Dis Child 2015; 100:869-71.

37.Uhrich S., Wu Z., Huang J.-Y. et al. Four mutations in the SI gene are responsible for the majority of clinical symptoms of CSID. J Pediatr Gastroent Nutr 2012; 55(Suppl 2):S34- S35.

38.Robayo-Torres C.C., Opekun A.R., Quezada-Calvillo R. et al. 13C-breath tests for sucrose digestion in congenital sucrase isomaltase-deficient and sacrosidase-supplemented patients. J Pediatr Gastroenterol Nutr 2009; 48:412-18.

39.Treem W.R. Clinical aspects and treatment of congenital sucrase-isomaltase deficiency. J Pediatr Gastroenterol Nutr 2012; 55:S7-S13.

40.Macdonald S. Carbohydrate intolerances. In: Shaw V. ed. Clinical paediatric dietetics, 4th edn. Chichester: Wiley Blackwell; 2015. P. 121-3.

41.Murray I.A., Coupland K., Smith J.A. et al. Intestinal trehalase activity in a UK population: estabilishing a normal range and the effect of disease. Br J Nutr 2000: 83; 241-5.

42.Arola H., Koivula T., Karvonen A.L. et al. Low trehalase activity is associated with abdominal symptoms caused by edible mushrooms. Scand J Gastroenterol 1999 Sep; 34(9):898-903. PubMed PMID: 10522609.

43.Gibson P.R. History of the low FODMAP diet. J Gastroenterol Hepatol 2017 Mar; 32(Suppl 1):5-7. doi: 10.1111/jgh.13685. Review. PubMed PMID: 28244673.

44.Ganiats T.G., Norcross W.A., Halverson A.L. et al. Does Beano prevent gas? A double-blind crossover study of oral alpha-galactosidase to treat dietary oligosaccharide intolerance. J Fam Pract 1994; 39(5):441-5.

45.Hillila M., Fakkila M.A., Sipponen T. et al. Does oral alpha-galactosidase relieve irritable bowel symptoms? Scand J Gastroenterol 2016; 51(1):16-21.

46.Di Nardo G., Oliva S., Ferrari F. et al. Efficacy and tolerability of alpha-galactosidase in treating gas-related symptoms in children. A randomized, double-blind, placebo-controlled trial. BMC Gastroenterol 2013; 13:142.

47.Banasiewicz T., Krokowicz L., Stojcev Z. et al. Micro-encapsulated sodium butyrate reduces the frequency of abdominal pain in patients with irritable bowel syndrome. Colorectal Dis 2013; 15:204-9.

48.Kannampalli P., Shaker R., Sengupta J.N. Colonic butyrate- algesic or analgesic? Neurogastroenterol Motil 2011; 23:975-9.

49.Tana C., Umesaki Y., Imaoka A. et al. Altered profiles of intestinal microbiota and organic acids may be the origin of symptoms in irritable bowel syndrome. Neurogastroenterol Motil 2010; 22(5):512-9.

50.Monsbakken K., Vandvik P., Farup P. Perceived food intolerance in subjects with irritable bowel syndrome -- Etiology, prevalence and consequences. Eur J Clin Nutr 2006; 60:667-72.

51.Simren M., Mansson A., Langkilde A.M. et al. Food-related gastrointestinal symptoms in the irritable bowel syndrome. Digestion 2001; 63:108-15.

52.Miller L.E., Tennilд J., Ouwehand A.C. Efficacy and tolerance of lactitol supplementation for adult constipation: a systematic review and meta-analysis. Clin Exp Gastroenterol 2014; 7:241-8.

53.Hayes P., Corish C., O'Mahony E., Quigley E.M. A dietary survey of patients with irritable bowel syndrome. J Hum Nutr Diet 2014; 27:36-47.

54.Wilder-Smith C.H., Materna A., Wermelinger C. et al. Fructose and lactose intolerance and malabsorption testing: the relationship with symptoms in functional gastrointestinal disorders. Aliment Pharmacol Ther 2013; 37:1074-83.

55.Saad R.J., Chey W.D. Breath tests for gastrointestinal disease: the real deal or just a lot of hot air? Gastroenterology 2007; 133(6):1763-6.